Levaquin and Hydroxyurea drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levaquin and Hydroxyurea. Common interactions include bacteraemia among females and fatigue among males.

The phase IV clinical study analyzes what interactions people who take Levaquin and Hydroxyurea have. It is created by eHealthMe based on reports of 96 people who take Levaquin and Hydroxyurea from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 06, 2023

96 people who take Levaquin and Hydroxyurea together, and have interactions are studied.


What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 55,045 Levaquin users for its effectiveness, alternative drugs and more.

What is Hydroxyurea?

Hydroxyurea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 13,918 Hydroxyurea users for its effectiveness, alternative drugs and more.

Number of Levaquin and Hydroxyurea reports submitted per year:

Levaquin and Hydroxyurea drug interactions.

Common Levaquin and Hydroxyurea drug interactions by gender *:

female:

  1. Bacteraemia
  2. Chest pain
  3. Cytomegalovirus viraemia
  4. Leukaemia
  5. Lung infection
  6. Metabolic encephalopathy
  7. Pain in extremity
  8. Platelet count decreased
  9. Pruritus
  10. Rash maculo-papular

male:

  1. Fatigue
  2. Anaemia
  3. Pyrexia
  4. Acute myeloid leukaemia
  5. Hypotension
  6. Respiratory failure
  7. Blood creatinine increased
  8. Pancytopenia
  9. Urinary retention
  10. White blood cell count decreased

Common Levaquin and Hydroxyurea drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Respiratory syncytial virus infection
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Chest pain
  5. Clostridium difficile colitis
  6. Colonoscopy
  7. Death
  8. Epstein-barr virus infection
  9. Hypersensitivity
  10. Mycobacterial infection

20-29:

  1. Dyspnoea
  2. Unresponsive to stimuli

30-39:

  1. Acute myeloid leukaemia
  2. Cellulitis
  3. Death
  4. Fatigue
  5. Pancytopenia
  6. Stomatitis

40-49:

  1. Concomitant disease progression
  2. Diarrhoea
  3. Erythema
  4. Feeling hot
  5. Gastroenteritis
  6. Haemolysis
  7. Haemosiderosis
  8. Jaundice
  9. Klebsiella infection
  10. Lobar pneumonia

50-59:

  1. Febrile neutropenia
  2. Mucosal inflammation
  3. Hypotension
  4. Respiratory failure
  5. Cytomegalovirus viraemia
  6. Metabolic encephalopathy
  7. Vaginal haemorrhage
  8. Acute myeloid leukaemia
  9. Atelectasis
  10. Cerebral infarction

60+:

  1. Anaemia
  2. Fatigue
  3. Acute myeloid leukaemia
  4. Hypoxia
  5. Blood creatinine increased
  6. Blood pressure decreased
  7. Chills
  8. Lung infection
  9. Oxygen saturation decreased
  10. Pulmonary mass

Common conditions people have *:

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 40 people, 41.67%
  2. High Blood Pressure: 16 people, 16.67%
  3. Pain: 14 people, 14.58%
  4. Nausea (feeling of having an urge to vomit): 13 people, 13.54%
  5. Primary Myelofibrosis (primary disorder of the bone marrow): 11 people, 11.46%
  6. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 11 people, 11.46%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 10.42%
  8. Stress And Anxiety: 6 people, 6.25%
  9. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 6 people, 6.25%
  10. Itching: 6 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Levaquin and Hydroxyurea?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Levaquin and Hydroxyurea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levaquin side effects:

Browse all side effects of Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Hydroxyurea side effects:

Browse all side effects of Hydroxyurea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levaquin interactions:

Browse all interactions between Levaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Hydroxyurea interactions:

Browse all interactions between Hydroxyurea and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levofloxacin and hydroxyurea (the active ingredients of Levaquin and Hydroxyurea, respectively), and Levaquin and Hydroxyurea (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Levaquin and Hydroxyurea.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: